Carina S. D. Wink

GC-MS, LC-MSn, LC-high resolution-MSn, and NMR studies on the metabolism and toxicological detection of mesembrine and mesembrenone, the main alkaloids of the legal high “Kanna” isolated from Sceletium tortuosum

Golo M. J. Meyer, Carina S. D. Wink, Josef Zapp et al. · Analytical and Bioanalytical Chemistry · 2014 · 33 citations

Pharmacy, Biochemistry, Toxicology +11

Lefetamine‐derived designer drugs<i>N</i>‐ethyl‐1,2‐diphenylethylamine (NEDPA) and<i>N‐iso</i>‐propyl‐1,2‐diphenylethylamine (NPDPA): Metabolism and detectability in rat urine using GC‐MS, LC‐MSⁿand LC‐HR‐MS/MS

Carina S. D. Wink, Golo M. J. Meyer, Dirk K. Wissenbach et al. · Drug Testing and Analysis · 2014 · 21 citations

Pharmacy, Pharmacology, Toxicology +14

Studies on the in vivo contribution of human cytochrome P450s to the hepatic metabolism of glaucine, a new drug of abuse

Golo M. J. Meyer, Markus R. Meyer, Carina S. D. Wink et al. · Biochemical Pharmacology · 2013 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +16

Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC‐MS, LC‐MSⁿ, and LC‐HR‐MSⁿ

Carina S. D. Wink, Julian A. Michely, Andrea Jacobsen‐Bauer et al. · Drug Testing and Analysis · 2016 · 17 citations

Pharmacy, Clinical Toxicology, Toxicology +13

Toxicokinetics of lefetamine and derived diphenylethylamine designer drugs—Contribution of human cytochrome P450 isozymes to their main phase I metabolic steps

Carina S. D. Wink, Golo M. J. Meyer, Markus R. Meyer et al. · Toxicology Letters · 2015 · 15 citations

Medicine, Pharmacology, Toxicology +16